REFERENCES
- Dongier M, Vachon L, Schwartz G. Bromocriptine in the treatment of alcohol dependence. Alcohol Clin Exp Res 1991; 15(6):970–977.
- Naranjo CA, Dongier M, Bremner KE. Long-acting injectable bromocriptine does not reduce relapse in alcoholics. Addiction 1997; 92(8):969–978.
- Borg V. Bromocriptine in the prevention of alcohol abuse. Acta Psychiatr Scand 1983; 68(2):100–110.
- Shaw GK, Majumdar SK, Waller S, MacGarvie J, Dunn G. Tiapride in the long-term management of alcoholics of anxious or depressive temperament. Br J Psychiatry 1987; 150:164–168.
- Walter H, Ramskogler K, Semler B, Lesch OM, Platz W. Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials. J Biomed Sci 2001; 8(1):83–88.
- Stahl SM. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: Illustrating their mechanism of action. J Clin Psychiatry 2001; 62(12):923–924.
- Beresford TP, Clapp L, Martin B, Wiberg JL, Alfers J, Beresford HF. Aripiprazole in schizophrenia with cocaine dependence: A pilot study. J Clin Psychopharmacol 2005; 25(4):363–366.
- Warsi M, Sattar SP, Bhatia SC, Petty F. Aripiprazole reduces alcohol use. Can J Psychiatry 2005; 50(4):244.
- Stoops WW, Lile JA, Glaser PE, Rush CR. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug Alcohol Depend 2006; 84(2):206–209.
- Ingman K, Kupila J, Hyytia P, Korpi ER. Effects of aripiprazole on alcohol intake in an animal model of high-alcohol drinking. Alcohol Alcohol 2006; 41:391–398.
- Blanken P, Hendriks V, Pozzi G, Tempesta E, Hartgers C, Koeter M, Fahrner EM, Gsellhofer B, Küfner H, Kokkevi A, Uchtenhagen A. European Addiction Severity Index. A Guide to Training and Administering EuropASI Interviews. Belgium: Bruxelles, COST Report, 1994.
- Sullivan JT, Sykora K, Schneideman J, , et al. Assessment of alcohol withdrawal: the revised clinical Institute Withdrawal Assessment for Alcohol scale (CIWA Ar). Br J Addict 1989; 84:1353–1357.
- Janiri L, Calvosa F, Dario T, Pozzi G, Ruggeri A, Addolorato G, Di Giannantonio M, De Risio S. The Italian version of the Obsessive-Compulsive Drinking Scale: Validation, comparison with the other versions, and difference between type 1- and type 2-like alcoholics. Drug Alcohol Depend 2004; 74(2):187–195.
- Derogatis LR, Lipman RS, Covi L. SCL-90: An outpatient psychiatric rating scale: Preliminary report. In ECDEU Assessment Manual for Pychopharmacology. Guy W ed. Revised 1976. DHEW Publication No. (ADM) 1976; 76–338.
- Guy W (ed.) ECDEU Assessment Manual for Pychopharmacology. Publication ADM 76–338. Washington, DC: U.S. Department of Health, Education, and Welfare, 1976; 218–222.
- Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis 1981; 34(12):585–597.
- Verheul R, van den Brink W, Geerlings P. A three-pathway psychobiological model of craving for alcohol. Alcohol 1999; 34(2):197–222.
- Christensen AF, Poulsen J, Nielsen CT, Bork B, Christensen A, Christensen M. Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study. Acta Psychiatr Scand 2006; 113(2):148–153.